100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
TEST BANK FOR RUPPEL’S MANUAL OF PULMONARY FUNCTION TESTING 11TH EDITION BY MOTTRAM £12.67   Add to cart

Exam (elaborations)

TEST BANK FOR RUPPEL’S MANUAL OF PULMONARY FUNCTION TESTING 11TH EDITION BY MOTTRAM

 4 views  0 purchase
  • Module
  • RUPPEL’S MANUAL OF PULMONARY FUNCTION TESTING 11TH
  • Institution
  • RUPPEL’S MANUAL OF PULMONARY FUNCTION TESTING 11TH
  • Book

TEST BANK FOR TEST BANK FOR RUPPEL’S MANUAL OF PULMONARY FUNCTION TESTING 11TH EDITION BY MOTTRAM Chapter 1: Indications for Pulmonary Function Testing Test Bank MULTIPLE CHOICE 1. Who first popularized spirometry for the evaluation of pulmonary function? a. August and Marie Krogh b. Alvan Barach...

[Show more]

Preview 4 out of 205  pages

  • August 28, 2024
  • 205
  • 2024/2025
  • Exam (elaborations)
  • Questions & answers
  • RUPPEL’S MANUAL OF PULMONARY FUNCTION TESTING 11TH
  • RUPPEL’S MANUAL OF PULMONARY FUNCTION TESTING 11TH
avatar-seller
TEST BANK FOR RUPPEL’S MANUAL
u u u u


OF PULMONARY FUNCTION TESTING
u u u u


11 TH EDITION BYMOTTRAM BRAND
u u u u u u


NEW2024/2025.
u

,Chapter u1: uIndications ufor uPulmonary uFunction uTesting
uTestuBank




MULTIPLE uCHOICE

1. Who ufirst upopularized uspirometry ufor uthe uevaluation uof upulmonary ufunction?
a. August uand uMarie uKrogh
b. Alvan uBarach
c. John uSeveringhaus
d. John uHutchinson

ANS: uD
Hutchinson upopularized uthe uconcept uof uusing uVC uto uassess ulung ufunction, uand uthe
unames uheugave uto useveral uother ulung ucompartments uare ustill uused utoday.


DIF: 1 REF: p. u2 OBJ: None u MSC: uNBRC: uNone

2. Which uof uthe ufollowing uare uindications ufor uperforming uspirometry?
1. Assess uthe urisk uof ulung uresection.
2. Determine uthe uresponse uto ubronchodilator utherapy.
3. Assess uthe useverity uof urestrictive ulung udisease.
4. Quantify uthe uextent uof uCOPD.
a. 1 u and u u4
b. 2 u and u u3
c. 1 u, u2, uand u u4
d. 2 u, u3, uand u u4

ANS: uC
Spirometry ucannot uassess useverity uof urestriction; ufor uthat uyou uneed uto umeasure ulung
uvolumes u(usee uBox u1-2, uChapter u u1).


DIF: 1 REF: p. u7 OBJ: EL-2 MSC: uNBRC: uNone

,3. The umain uindication ufor uthe umeasurement uof ulung uvolumes uis uto udo uwhich uof uthe
ufollowing?

a. Diagnose uor uassess uthe useverity uof urestriction.
b. Evaluate uthe useverity uof upulmonary uhypertension.
c. Determine uthe ulevel uof ucardiopulmonary ufitness.
d. Assess uthe urisk uof uabdominal usurgical uprocedures.

ANS: uA
The umost ucommon ureason ufor umeasuring ulung uvolumes uis uto uidentify urestrictive ulung

udisease.uDIF: 1 REF: p. u35 OBJ: EL-2 MSC: uNBRC: uNone

4. DLCO umeasurements umay ube uindicated uto uevaluate upulmonary uinvolvement uin uwhich
uof utheufollowing usystemic udiseases?

a. Asthma
b. Sarcoidosis
c. Exertional uhypoxemia

, Stuvia.com u- uThe uMarketplace uto uBuy uand uSell uyour
uStudy uMaterial

d. Guillain-Barré usyndrome

ANS: uB
Sarcoidosis uis uthe uonly usystemic udisease ulisted uthat uaffects ugas

uexchange.uDIF: u1 uREF: up. u9 u| up. u19 u| up. u21 u| up. u35 uOBJ: uEL-2


uMSC: uNBRC: uNone


5. Blood ugas uanalysis uis uused uwith upatients uwith uCOPD uto udo
uwhich uof utheufollowing?

a. Monitor uairway uresponsiveness.
b. Determine ulevel uof ucardiopulmonary ufitness.
c. Detect upulmonary uhypertension.
d. Assess uneed ufor usupplementary uO2.

ANS: uD
Blood ugas uanalysis uis umost ucommonly uused uto udetermine uthe uneed ufor usupplemental
uoxygenuand uto umanage upatients uwho urequire uventilatory usupport.


DIF: 2 REF: p. u15 OBJ: EL-1
uMSC: uNBRC: uCPFT u2A-2


6. Which uof uthe ufollowing ucause uemphysema?
1. 1- uAntitrypsin udeficiency
2. Exposure uto uenvironmental upollutants
3. Radiation utherapy
4. Cigarette usmoking
a. 1 u and u u2
b. 3 u and u u4
c. 1 u, u2, uand u u4
d. 2 u, u3, uand u u4

ANS: uC
Emphysema uis ucaused uprimarily uby ucigarette usmoking. uSome uemphysema uis ucaused uby
utheuabsence uof ua uprotective uenzyme. uChronic uexposure uto uenvironmental upollutants ucan
ualso ucontribute uto uthe udevelopment uof uemphysema.


DIF: 1 REF: p. u11 OBJ: EL-3 u| uAL-2 MSC: uNBRC: uNone

7. An uadult upatient ucomplains uof uchest utightness uand ucough uwhenever uhe ujogs uin ucold
uweather.uThese usymptoms uare uconsistent uwith uwhich uof uthe ufollowing?

a. Cystic ufibrosis
b. Asthma
c. Pulmonary uhypertension
d. Idiopathic upulmonary ufibrosis

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller Prose1. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for £12.67. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

67096 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy revision notes and other study material for 14 years now

Start selling
£12.67
  • (0)
  Add to cart